Dermatophytoma caused by terbinafine‐resistant Trichophyton rubrum treated with fosravuconazole
Dermatophytoma caused by terbinafine‐resistant Trichophyton rubrum treated with fosravuconazole
复制标题
福斯拉康唑治疗耐特比萘芬红色毛癣菌引起的皮肤癣菌
DOI:
10.1111/1346-8138.16480
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
R. Kano
中科院分区:
文献类型:
--
作者:
H. Noguchi;Tadahiko Matsumoto;Masahide Kubo;Utako Kimura;M. Hiruma;T. Yaguchi;Tsuyoshi Yamada;R. Kano
Dear Editor, Terbinafineresistant dermatophyte strains have increased over the past decade worldwide. We successfully treated a patient with tinea unguium caused by a terbinafineresistant Trichophyton rubrum (Phe397Leu substitution in squalene epoxidase; SQLE).1 Therewith, dermatophytoma was described in 1998 as a unique type of tinea unguium seen in some distal and lateral subungual onychomycosis, characterized by densely packed clump of dermatophyte hyphae and large arthroconidia, or both, compacted and forming a fungal ball.2 Definitive diagnosis is made microscopically by observation of fungal conglomerate via KOH method. Dermatophytomas are recalcitrant to standard oral antifungal medications.2 Herein, we treated a patient with dermatophytoma caused by terbinafineresistant T. rubrum with oral fosravuconazole. An 81yearold male farmer with type 2 diabetes (hemoglobin A1c, 7.0%) presented to our clinic with tinea corporis (buttocks) in June 2020. He was taking aspirin, amlodipine, and olmesartan regularly. The isolate was identified as terbinafineresistant T. rubrum